Exasol (EXL) Q1 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 TU earnings summary
8 Jul, 2026Executive summary
Q1 2025 revenue rose 25.3% year-over-year to €12.4 million, driven by one-off hardware and service deals in focus verticals, with EBITDA at €1.3 million and net income at €1.0 million, both up significantly from the prior year.
Focus verticals delivered 14.6% ARR growth to €24.4 million, now representing 61% of the portfolio, up from 52% year-over-year.
Total ARR declined 2.2% year-over-year to €40.0 million, mainly due to significant churn and a major downsell in non-focus verticals.
Liquidity reached €23.2 million, the highest since mid-2022, providing strong operational and strategic flexibility.
Profitability improved, supporting the ongoing strategic shift toward regulated industries and focus-verticals.
Financial highlights
Q1 2025 EBITDA improved to €1.3 million from €0.3 million in Q1 2024; net income swung to €1.0 million from a €0.2 million loss.
Revenue growth was driven by a one-off €2.9 million hardware and services delivery to existing customers.
FY 2024 audited revenue was €39.6 million, up €4.5 million from FY 2023; adjusted EBITDA reached €2.0 million, a €7.4 million improvement year-over-year.
Gross profit margin improved by approximately 3% after adjusting for R&D subsidies.
Personnel expenses reduced to €6.2 million from €6.7 million year-over-year.
Outlook and guidance
Full-year 2025 guidance confirmed: mid-single-digit growth in ARR and revenue, with EBITDA targeted at €3–4 million, at least 50% higher than prior year.
ARR expected to decline temporarily in H1 2025, with net ARR growth resuming in H2 2025 as focus verticals expand and churn stabilizes.
Continued focus on growing business in financial services, healthcare, telecom, utilities, and public sector in EMEA/DACH.
Anticipate recurring, though not predictable, hardware/service deals in future quarters, but not at Q1's exceptional size.
Latest events from Exasol
- Profitable H1 2024 with 12% ARR growth, 9% revenue growth, and strong liquidity.EXL
H1 20248 Jul 2026 - ARR decline slowed, churn improved, and 2026 guidance for growth and EBITDA was confirmed.EXL
Q1 2026 TU15 May 2026 - First-ever positive EBITDA and net income, with strong sector growth and robust 2025 outlook.EXL
Q4 2024 TU15 May 2026 - 2025 saw robust growth, AI integration, and improved profitability, with ARR set to rise in 2026.EXL
Q4 202519 Mar 2026 - EBITDA and net income surged, with focus industries driving ARR growth despite overall ARR decline.EXL
Q4 2025 TU3 Feb 2026 - Positive EBITDA and double-digit growth achieved, with focus on regulated, hybrid markets.EXL
Q3 2024 TU14 Jan 2026 - Revenue up 10.8%, profitability rose, and focus verticals now drive 69% of ARR.EXL
Q2 202523 Nov 2025 - Revenue and EBITDA up, ARR down 4.1%; focus verticals and MariaDB to drive 2026 growth.EXL
Q3 2025 TU12 Nov 2025 - ARR fell 4.1% on high churn, but focus verticals and partnerships set up for 2026 growth.EXL
Trading Update27 Oct 2025